Galena Biopharma to Present at the Oppenheimer 23rd Annual Healthcare Conference

Galena Biopharma to Present at the Oppenheimer 23rd Annual Healthcare
Conference

LAKE OSWEGO, Ore., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc.
(Nasdaq:GALE), a biotechnology company focused on developing innovative,
targeted oncology treatments that address major unmet medical needs to advance
cancer care, today announced that Mark J. Ahn, Ph.D., President and CEO, will
present a corporate overview at the Oppenheimer 23^rd Annual Healthcare
Conference. The presentation will take place on Thursday, December 13, 2012 at
3:55 p.m. EST at The Waldorf-Astoria Hotel in New York, NY.

The presentation will be webcast and available on the Company's website at
http://investors.galenabiopharma.com/events.cfm.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based
biopharmaceutical company that develops innovative, targeted oncology
treatments that address major unmet medical needs to advance cancer care.For
more information please visit us at www.galenabiopharma.com.

The Galena Biopharma, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=10647

CONTACT: Madeline Hatton
         Toll free: +1 (855) 855-GALE (4253), ext. 109
         info@galenabiopharma.com

         or

         Remy Bernarda
         IR Sense, LLC
         +1 (503) 400-6995
         remy@irsense.com

Galena Biopharma, Inc.
 
Press spacebar to pause and continue. Press esc to stop.